<DOC>
	<DOC>NCT01672333</DOC>
	<brief_summary>Early stage diagnosis of gastric cancer has ensued different approaches in its resection strategies. In order to increase the proportion of cases that undergo radical resection and reduce the recurrence rate, different pre-operative treatments are introduced. Here, the investigators investigate an active preoperative chemotherapeutic regimen to in patients with locally advanced gastric cancer.</brief_summary>
	<brief_title>Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Tissue diagnosis of gastric or gastroesophageaql junction Adenocarcinoma T3, T4 any N with non metastatic condition Age 18 70 years Performance status 0,1 according to ECOG criteria Adequate bone marrow , liver and renal function Hemoglobin ≥ 11 g/dl Platelets ≥ 100000 / mm3 Absolute Neutrophil Count ≥ 1500/mm3 Normal Bilirubin Normal Transaminases Normal creatinin Absence of active comorbid illness (uncontrolled infection, uncontrolled DM, cardiopulmonary disease) Any metastatic disease, T1, T2, N0</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>